Tag Archives: Severe

FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes

FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon)… Read More »

Covid vaccine side effects: Anaphylaxis is a rare but severe allergic reaction

The Oxford-AstraZeneca and Pfizer-BioNTech vaccines appear to be exceeding even the most optimistic expectations. New data released by Public Health England (PHE) shows that a single shot of either vaccine reduces the chance of needing hospital treatment by more than 80 percent. For most people, getting a jab will cause only mild and short-lived side… Read More »

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain Print this page ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults… Read More »

Triple therapy helps control severe asthma

Asthma affects approximately 20 million adults in the US. It is a common cause of workplace and school absenteeism, and is one of the leading causes of hospitalizations in the US. Between 5% and 10% of asthmatics have frequent, persistent symptoms despite treatment with multiple medications, and are categorized as “difficult to treat” and “severe”… Read More »

FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain

FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain Print this page CHESTERBROOK, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that the U.S. Food and Drug… Read More »

Health of people with dementia dealt a severe blow by coronavirus lockdown

People with dementia have suffered an alarming deterioration in their health and wellbeing during the Covid-19 pandemic, a stark new report warns today. EOPLE with dementia have suffered an alarming deterioration in their health and wellbeing during the Covid-19 pandemic, a stark new report warns today. Lockdown and the closure of vital day services and… Read More »